Free Trial

Lipella Pharmaceuticals (LIPO) SEC Filings & 10K Form

Lipella Pharmaceuticals logo
$0.59 -0.01 (-1.22%)
As of 08/22/2025 02:47 PM Eastern

Recent Lipella Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/14/2025
4:07 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2025
2:14 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
3:25 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
4:05 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
8:19 PM
Huang Leaf (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/14/2025
5:08 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
7:39 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
7:43 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
4:06 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
6:16 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:20 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/07/2025
5:05 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
4:14 PM
Lipella Pharmaceuticals (Filer)
Form 424B5
04/03/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
5:21 AM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2025
6:56 PM
Lipella Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
5:23 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/18/2025
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
7:18 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/17/2025
7:12 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:01 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:09 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/11/2025
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:28 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:32 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
02/10/2025
4:35 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:27 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:28 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:08 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:11 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/17/2025
7:13 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
7:17 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/16/2025
5:51 AM
Lipella Pharmaceuticals (Filer)
Form 424B3
01/15/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
01/13/2025
7:42 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/07/2025
4:28 PM
Lipella Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/06/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
8:22 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:25 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.tc pixel

This little-known company holds nearly 100 patents and trades for around $7
12/30/2024
3:11 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
8:28 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
8:31 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/27/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:29 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:24 PM
Lipella Pharmaceuticals (Filer)
Form PRE 14A
11/01/2024
4:00 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:00 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
10/17/2024
4:00 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
09/11/2024
4:10 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LIPO) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners